Maybe. But annualised earnings based on the first half is only 8c, so at $1.10 P/E is 13.75 on a stock with effectively one product with headwinds and a retreat in this half alone. Even if they do come home with a wet sail and get 12c, circa ten times is still too pricey for me on what is currently a one hit wonder.
Need to see those other products hitting the market to diversify AND increase revenue.
I like Acrux and its PDF status, but not at these prices and current outlook.
Add to My Watchlist
What is My Watchlist?
